___mtm im - bio- 3-9-15

MTM HEALTHCARE SOLUTIONS INC. 1 CONFIDENTIAL

INFORMATION MEMORANDUM

March 2015


The Investment Summary (the “Summary”) has been prepared by MTM Healthcare Solutions Inc. (hereinafter referred to as “MTM” or the “Company”) for information purposes, a Florida Corporation. THIS SUMMARY DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY SECURITY.

The information contained herein has been prepared to assist interested parties in making their own evaluation of the Company, and does not purport to contain all of the information that a prospective investor may require. In all cases, interested parties should conduct their own investigation and analysis of the Company and the data set forth in this Summary and further documents transmitted to the recipient in the course of their evaluation of the Company. This Summary is intended to give potential investors the opportunity to review a summary of information about the Company that may not fully represent every aspect of the Company’s business. The Company shall have no liability for any representations (expressed or implied) contained in, or for any omissions from, this Summary or any other written or oral communications transmitted to the recipient in the course of their evaluation of the Company. The Company undertakes no obligation to update or revise, publicly or privately, any forward looking statement, whether as a result of new information, future events or otherwise. By accepting this Investment Summary, the recipient agrees that (i) it will not copy or otherwise reproduce this document in whole or in part, or distribute it, or disclose the information contained herein, to others at any time, and (ii) the recipient will not use the information contained herein for any purpose other than to determine whether to pursue the potential transaction. This Summary includes various remarks about the Company's future expectations, plans and prospects that may constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Such remarks are valid only as of today, and the Company disclaims any obligation to update this information. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in this Summary. All inquiries regarding the proposed transaction and all requests for additional information should be directed to:

Frederick Schlosser, President & CFO

1471 S.W. 30th Ave. Unit #2

Deerfield Beach, FL 33442

Phone: 914-319-8190

[email protected]

SUMMARY


MTM Healthcare Solutions Inc. (“MTM”), headquartered in Deerfield Beach, Florida, is a full service retail pharmacy that provides innovative packaging by the dose for the distribution of prescription medications, vitamins and supplements, and over-the-counter (OTC) medications, directly to the consumer. MTM distributes customized pouch packs to consumers whose lives or well-being depend on strict medication management of difficult or sophisticated drug regimens. MTM will focus on two primary Direct-to-Consumer markets – patients with acute medication needs, especially older patients; along with their family caregivers. Both of these targets are currently dramatically underserved by America’s multi-billion dollar pharmaceutical dispensing marketplace. This underserved status – known as Medication Mismanagement – leads to more than 125,000 deaths in America each year, as well as $317 billion in healthcare costs involved in treating patients who have made mistakes when taking their medications. These patients, because of their at-risk status, as well as the costs involved in treating them for Medication Mismanagement, currently represent a significant consumer demand for the products and services MTM provides. In addition, these two target markets have an enormous and demographically-predictable potential for rapid, sustained business growth and profitability. Unlike any other pharmacy business, including typical mail-order pharmacies, MTM – along with its one of a kind partnering arrangement with one of the largest Pharmaceutical/ drug wholesaler in the world – has been designed from the ground up to focus on serving the needs of customers (and their caregivers) whose lives and well being are dependent on strict adherence to sophisticated and often complicated medication regimens. To maximize their health and quality of life, these customers must take multiple doses of multiple medications at many specific times throughout each day. They are also the healthcare patients most likely to make significant and even life-threatening mistakes on a regular basis when taking their medications – commonly referred to as Medication Mismanagement.

Millions of Americans suffer the threat of Medication Mismanagement every day. In fact, if Medication Mismanagement were classified as a disease, it would rank as the fifth leading cause of death in America.

The ultimate tragedy is that the vast majority of these deaths can be easily prevented. Therefore, classified as the fifth leading cause of death, Medication Mismanagement is also America’s number one cause of preventable deaths.

In addition to this precious human cost, Medication Mismanagement also exacts a heavy economic toll. The medical complications resulting from Medication Mismanagement costs American patients, caregivers, healthcare providers and healthcare insurers an estimated $317 billion each year.

MTM confronts this deadly and costly threat with a practical and highly effective solution, one that has been shown to reduce or eliminate the instances and effects of Medication Mismanagement. Each year, MTM’s solution has the potential to save the American healthcare


system tens to hundreds of billions of dollars in unnecessary healthcare costs, and could save tens of thousands of American lives each year.

Until now, the vast majority of prescription medications have been dispensed and delivered to consumers in the ubiquitous “amber bottles.” It has been up to the customer and/or the caregiver to manage these bulk medications – primarily by sorting pills and capsules from their bottles into their personal medication organizer. It is then up to them to administer these medications to themselves at the proper time, in the proper order and according to the specific, often complicated and conflicting instructions and precautions.

MTM will utilize a specialized patented technology developed by our partners to dispense all the medications that a given customer is required to take at a particular time. Proprietary software will screen all prescription drugs, vitamins and supplements for interactions and set out compliance requirements. Then the patient’s prescriptions are packaged together in an easy to use packet that is labeled by name, date, and time packaged sequentially in a perforated strip and, as noted, they are labeled for clarity. All the customer or family caregiver has to do is read the date and time, and tear off the packet – all the medications they need at any given time are there in one convenient, reliable package. No more juggling pill bottles or filling those little plastic trays labeled with days or weeks. Both of those approaches are time consuming; and worse, they are often the source of many costly and potentially life-threatening medication errors.

New business models such as MTM’ are being developed and are sorely needed – these emerging strategies are critical for true care coordination that will help ensure better health outcomes – not to mention independence and the peace of mind achieved through the ease of personal medication management. The scope of this issue has been highlighted by the American Heart Association (AHA), which reports that medication non-adherence is the #1 problem in treating illness today.

Fully two-thirds of all American patients – regardless of age – do not routinely take their medications as prescribed. In addition, a stunning 60% of paid caregivers at least occasionally make mistakes when simply sorting their patients’ medications. Clearly, this traditional method of dispensing, delivering, managing and administering medications is at the heart of the Medication Mismanagement crisis.

The MTM solution combines award-winning state-of-the-art technology, time-tested best practices and a common-sense, but highly effective, approach to medication compliance. This MTM solution yields a far simpler, far more convenient, far safer and far more satisfying consumer experience. It eliminates the amber bottle, the pillbox organizer, confusing and conflicting instructions and, as a result, it also eliminates the vast majority of medication compliance problems. MTM’s solution can significantly reduce the threat and instances of Medication Mismanagement for all segments of the targeted customer and caregiver populations.

Competition: There are currently no regional or national retail pharmacies in the marketplace actively offering multi-dose packaging exclusively for Direct-to-Consumer individual prescription medications. However, this AmerisourceBergen-patented technology is currently being used by cutting-edge closed-access patient care organizations, such as nursing homes and


hospitals, to meet and optimize internal needs that have static populations and static formularies. Additionally, in the last 8 months a fledgling company called Pillpack has entered the market and has begun to acquire some customers. They do not have a large customer base as yet. Management views this as a positive as it substantiates MTM’s view of the size of the market opportunity. MTM believes that it has a competitive advantage as a result of the operating and business process platform it has developed with the assistance of Amerisource Bergen.


INVESTMENT HIGHLIGHTS Market Opportunity: The aging of the U.S. population, coupled with the National

Healthcare Reform Act (ACA), which will be fully implemented in 2014, is expected to be a significant driver of prescription utilization in the coming years. MTM is poised to benefit from these positive market trends. The number of people in the U.S. age 65 years or older is projected to rise to 55 million by 2020 – up 36 percent from 2010 – and to continue to grow at a rate of 60% per decade, for at least the next four decades. In addition, because of the ACA, it is projected that at least 32 million more Americans will have health insurance in 2014 than are currently covered, fueling demand as never before. During that time, as more Americans are put on a continuous prescription regimen, the MTM synchronized medication management market will grow exponentially.

Proven Industry Talent: MTM has assembled a seasoned team of experienced executives,

along with advisors and consultants whose backgrounds include C-level experience with some of the world’s top pharmaceutical, healthcare, medical, marketing and investment banking firms. The management team not only has extensive experience in the medical and healthcare markets, it has developed a number of close personal and business relationships with healthcare industry leaders which will be utilized for the benefit of MTM, as well as for its customers. This management team and consulting/advisory team is an energized group, possessing the qualities critical to success. They bring to MTM a disciplined approach, a focus on accountability, confidence in themselves and one another, and an exceptional capacity to balance short-term results with long-term goals. Together, they symbolize leadership, optimism and determination.

Strategic Relationship: MTM plans to engage a multi-billion dollar drug wholesaler and

pharmacy consulting firm to provide staffing, management, technology and equipment needs for MTM’s complete pharmacy operations – this will facilitate scaling the business. ABC will be supplying MTM with their award-winning technology, the FastPak EXP, which has received the highest overall performance rating for High-Volume Unit Dose Packaging in the “Best in KLAS Awards: Medical Equipment & Infrastructure” competition. In 2012 KLAS recognized the FastPak EXP with its Best in KLAS award for the fourth year in a row.

Medication Mismanagement: Medication Mismanagement is a serious problem here in America, each year costing the healthcare system more than $317 billion, as well as the deaths of tens of thousands of loved ones, not to mention the millions of additional patients who are critically affected every year. Fifty-eight percent of all seniors make some kind of error when taking their medications, with 26% of all Seniors routinely making mistakes with potentially serious consequences. To illustrate MTM’s potential impact in terms of both lives and dollars saved, studies have shown that increasing medication adherence by just 50% could save as many as 80,000 lives in America every year and reduce annual U.S. healthcare costs by more than $145 billion.

Demand Cycles: With the aging of America and exponential growth of access to individual health insurance via the ACA, demand for MTM’s solution will be steady and continuously


growing. Equally important, the MTM market is not cyclical. Most of our customers MUST take their medications every day – if they don’t, they will stand a significant chance of suffering severe health repercussions, even risking death.

Marketing: MTM has developed one of the most cohesive, multi-channel marketing

strategies ever developed by a direct-to-the-consumer pharmacy. In addition, the entire marketing team has been honored many times as some of the top healthcare marketing and advertising specialists in the country.

Product Flexibility and Quality: MTM’s innovative pharmacy-product packaging system

organizes and sorts each patient’s daily medication regimen into convenient, safe, multi-dose packets. This system has the ability to include prescriptions, OTC medications, vitamins, and even supplements. Not only do we protect the patient from drug interactions, but our clinical services can prevent interactions between the patient’s medications, as well as vitamins and supplements, adding additional screening and safety to their daily activity. MTM provides the best opportunity for customers to take the right medication on the right day at the right time, every time!

Bottom Line: MTM has identified a virtually un-served market which represents tens of billions of dollars in potential annual revenue. To serve that market, MTM has developed a market-ready product, one which has built-in demand based on current financial and patient-care issues which are not being addressed by any existing companies currently in the consumer pharmaceuticals market. The MTM team has the experience, skill, market and marketing background, as well as the expertise necessary to bring this dynamic and profitable service-related product to market, first in Florida, then nationwide. Just as important, MTM will do so before any potential competitor can move to capture market share.

FINANCIALS

Year 1 Year 2 Year 3 Total Revenue $13,777,010 $235,325,901 849,357,450 COGS $11,090,873 $182,912,991 $644,543,611 Total Operating Expenses $6,462,783 $49,659,208 $140,834,464 # Customers 12,519 93,804 222,789 Total Net Income ($4,033,721) $1,705,592 $38,764,978


INDUSTRY OVERVIEW Even before the implementation of the Affordable Care Act in 2012, healthcare has been America’s fastest-growing industry. This will continue for at least the next four decades in large part because 10,000 “baby boomers” turn 65 each day. While other demographic groups will begin to replace the baby boomers after 2030 healthcare will remain a solid growth industry until at least 2050. That’s when the youngest cohort of baby boomers will reach 85 years of age. As the 78 million baby boomer generation ages, their demand for services will drive healthcare expenditures to as much as 25 percent of the GDP; and because age-related illnesses tend to be prescription-intensive, demand-driven growth for prescription pharmaceuticals will increase at more than 60% per decade for at least the next forty years. In the face of such guaranteed long-term growth-market demand, companies which can provide essential healthcare-related services are positioned to become remarkably profitable. MTM – because it has identified a high-volume, profitable healthcare prescription pharmaceutical market for multi-dose-packaged prescription pharmaceuticals – is particularly well-positioned to become a service-leader in this burgeoning marketplace.

In addition to demographic market growth, national healthcare reform will remain a major political and social issue in America. Because need-based demand is expected to outstrip the revenue to meet traditionally-delivered healthcare service supply, the movement to innovatively control costs while expanding access to care is on MTM’s side. Keeping patients out of the hospital has become a major focus of Medicare and Medicaid, as well as insurance companies. In order to accomplish this financially-driven balancing act, patients must keep healthy. Because, as noted, prescription drug non-compliance is the number one reason behind patient hospital readmissions, MTM anticipates strong and mandated support from payor groups, ranging from insurance companies to Medicare and Medicaid.

Furthermore, the U.S. retail pharmaceutical industry is currently both large and highly fragmented. It consists primarily of large national and regional multi-store operations, as well as a large – though decreasing – number of small, private, single unit and small, purely local one-market chain retailers. In addition, a fast growing segment of this market is being served by mail order and Internet-based dispensing pharmacies, including Canadian-based dispensing pharmacies. These businesses primarily serve those patients with high-cost prescriptions, as well as those patients who have a half-dozen or more prescriptions. Drug sales world-wide are approximately one trillion dollars, with the United States comprising over $300 billion of that market. In the U.S. alone, there are more than four billion prescriptions being filled each year – that’s more than 330 million prescriptions filled each month. In the face of this incredible demand, the retail dispensing pharmaceutical industry is experiencing a period of rapid consolidation. Smaller operators, which typically compete based on service, rather than price, are being driven out of the market because they lack the financial resources, economies of scale and management techniques required to compete with larger national providers. To remain competitive, retail pharmaceutical companies must have a unique market niche, one that brings tremendous perceived value to specific segments of the


prescription pharmaceutical market. In this dynamic market, specialty niche market companies are experiencing tremendous growth, and are rewarding their shareholders. Today, the global pharmaceutical industry is nearly a trillion dollar industry. As noted, this dynamic market is forecasted to continue its record growth through at least 2050 – nearly 40 years into the future. Some of this growth is based on scientific advances – as pharmaceutical researchers continue to make breakthroughs in medical applications, including new prescription medicines, people become more and more reliant on medication to lengthen and improve their quality of life. Much of this growth, however, is reliably driven by demographics. As the population ages, and as people anticipate living far beyond the traditional “three-score-and-ten” – as millions of Americans live healthy and vigorous lives well into their 80s and 90s – they have become increasingly reliant on prescription medication’s for both life-extension and quality-of-life reasons. However, as more people take more medicines, the opportunities for non-compliant Medication Mismanagement, for over-taking or under-taking of their prescribed medicines increases – or for mixing drugs that deliver unwelcomed and potentially life-threatening side-effects – increases. This further strengthens the demand for the kinds of services that will be uniquely offered by MTM. In response to the growth in demand for prescription pharmaceuticals, the dispensing pharmaceutical industry has taken on a variety forms, such as:

Chain pharmacies: These are regional or national chains such as Walgreens, Rite-Aid and CVS. In addition to these traditional free-standing pharmacy chains, retail pharmacy operations are being included in supermarkets, as well as in big-box stores (Wal-Mart). The advantages to these chains are better retail sale prices – which are made possible through economies of scale – as well as personalized level of face-to-face retail service. This personalized service includes taking the form of the chain having a record of your medication purchases as well as any allergies that patients have disclosed to them, supported by software programmed to identify potential drug interactions. The personalization increases when staff (pharmacists, pharmacy techs) remain stable over time, and begin to know the individual customers by name.

Local pharmacies: Far more than the chain pharmacies, these local operations are the

pharmacies where customers typically know the pharmacists – and the pharmacists know their customers’ medical histories. This option is high in personalized service and convenience, but they also reflect a higher per-prescription cost. As the costs of pharmaceuticals soar – especially the costs paid out-of-pocket by patients – these local pharmacies are losing out on price competition.

Mail order and Internet pharmacies: Internet-based retail dispensing pharmacies, both

free-standing and affiliated with organizations such as AARP, have created a new market pattern. This is a pattern that MTM will capitalize on when reaching out to high-volume individual patients.


Canadian pharmacies: These pharmacies are located in Canada where the cost of drugs is lower than in the U.S. These pharmacies can be accessed through mail order, the Internet, or via travel. MTM is positioned to compete with them on service, especially for patients who have experienced problems when managing their own multi-drug prescriptions.

OUR STRATEGY

MTM’s strategy is guided by our quest to leverage the power of the dispensing pharmacy to reform the way prescription medications are delivered. MTM’s innovative and distinctive delivery system should ultimately result in customers living longer, healthier lives, with the potential to actually save lives by minimizing Medication Mismanagement, while – for the same reason – working to reduce the total cost of healthcare. The Company’s business strategy includes a financial focus designed to deliver strong and steady earnings growth, In addition, MTM will build shareholder value through a series of strategic initiatives, including:

Phased launch: initial launch in Florida, and post proof of concept, expanding regionally and nationally.

Careful & strategic targeting of High-Value Clients; MTM will initially target “chronic” individual customers, along with their caregivers – by initially capturing chronic customers, MTM will grow based on demand and revenue. Chronic customers are those who take a significant number of different medications on an ongoing and sustained basis to deal with chronic healthcare problems such as diabetes, coronary artery disease and other “chronic” medical ailments

Strategic to Tactical Marketing: MTM’s strategic marketing plan is based on the

company’s detailed knowledge of the target markets, as well as a proven track record of healthcare marketing successes

Effective Operations: MTM will grow based on disciplined and effective selling,

supported by general and administrative expense control

Product-Line and Market Growth: MTM will grow via expanding its product and service offerings to new markets, in order to increase revenues

MTM’s primary strategic objective is to quickly and effectively establish itself as the retail pharmacy specializing in the delivery of “by the dose medications” to the tens of millions of individuals who are faced with the daunting and risky task of self-dosing with multiple medications on a daily and ongoing basis.

The primary MTM marketing strategy will initially seek to first create customer awareness among patients, physicians and family caregivers. This awareness will focus on the products/services that MTM will offer. Then, in each geographic market, MTM will first develop


the customer base and then work toward building customer loyalty and referrals. Ultimately, MTM will introduce its growing customer base to the Company’s other products and services, which will include, but not be limited to OTC medications, along with vitamins and supplements, and ultimately pet medicines.

MTM will successfully launch in the Direct-to-Consumer (DTC) marketplace over a three-year period. The Company’s in-depth Marketing and Communications Plan is designed to swiftly and effectively grow the business from start-up to marketplace dominance.

MTM’s integrated set of marketing, promotion, social networking and sales-support strategies and tactics will work together to build target-market awareness of the problems created by Medication Mismanagement, then turn that awareness into demand for the solution uniquely offered by MTM.

Essentially, the Company’s growth strategy involves leveraging the executive and consulting/advisory team’s many decades of personal healthcare industry contacts, along with the enormous experience possessed by MTM’s senior management team, consultants and advisors, in order to quickly seize national market dominance based on the Company’s unique products and services. MTM will accomplish this while, at all times maximizing profits. This will be achieved by constantly and aggressively improving margins through revenue growth and tightly managing operating costs throughout the Company’s range of healthcare and wellness-related services. MTM’s leadership team is setting out to take advantage of the rapidly changing healthcare delivery market place. In focusing on the bottom line, MTM is being very proactive in what is otherwise a reactive and passive industry.

MANAGEMENT MTM has assembled a team of experienced, committed leaders, sage advisors and consultants, along with a network of trusted, talented business partners who will, together, drive the Company from inception, funding and development through long-term growth and profitability. This team includes:

Frederick Schlosser: President & Chief Financial Officer Mr. Schlosser has more than 30 years of experience in the financial services industry in a range of senior management roles. Mr. Schlosser was most recently Managing Director at Solstice Strategies, LLC, a financial advisory firm. Prior to that, Mr. Schlosser was a Managing Director and Partner at Brevet Capital, a special opportunities hedge fund. He was the transactions and structuring partner, and sat on the investment committee. He was responsible for deploying in excess of $150 million in capital, in a variety of transactions including LS transactions. Previously he was the COO of Life Settlements International. While there, he reviewed, priced and bid on more than $6 billion in face, structured and executed a collateralized life settlement bond ($250,000,000 face) with Fortis Bank and CSC Trust Company as counterparties, and


structured and executed a cross-border LS deal with a German hedge fund. He facilitated the sale of LSI to Cantor Fitzgerald. Mr. Schlosser has been a CFO and COO of a variety of small companies, including acting as interim CFO of two publicly traded companies. Mr. Schlosser has been active in the private equity markets, both as an advisor to entrepreneurs and consulting for companies on matters of strategy, restructuring and financing.

Mr. Schlosser began his career with Price Waterhouse Coopers. He is a licensed CPA, has an undergraduate degree from Williams College and a MS in accounting from New York University’s Stern School of Business.

Judd Trayling: CTO Mr. Trayling is a proven technology leader with 19 years working in multiple industries, multiple solutions, and multiple roles as a consultant. Recently he is the founder of Roghnu, Inc. a web and mobile technology development and enterprise technology advisory company; was a Partner with Sunera, a leading IT and security risk management firm for 5 years; founder of Windward Innovations, a boutique ERP implementation and custom integration and solutions development company, a manager at KPMG for IT risk advisory. He has performed over 1000 IT risk related interviews with clients while performing project IV&V reviews and assessing their strengths and weakness further increasing his visibility to what works and what does not.

Mr. Trayling has delivered PeopleSoft ERP systems, custom application development and integration solutions in multiple industries for clients ranging from start-up to 100B global manufacturing companies. He has delivered projects at two of the largest automotive manufacturers and two of the largest beverage companies in the world. He holds a Bachelor of Science in Industrial Management with a minor in Manufacturing Management degree from Purdue University, has held the Project Management Institute PMP certification since 2004, is a Certified Software Development Professional (CSDP) through the Institute of Electrical and Electronics Engineers (IEEE) professional associations (since 2012), and has completed the Loyola University of Chicago Executive Education Management Certification Program and the University of Texas at Austin School of Engineering Software Project Management (SWPM) Certificate Program.

Robert Fear, EVP Business Development

Mr. Fear has over 20 years of sales, marketing, organizational, and project management experience. Mr. Fear has a proven ability to form and manage sales and marketing teams focused on fund raising, financial sales, direct sales, and direct marketing efforts. Mr. Fear began his career selling computer networks to Fortune 500 hundred companies at Ameridata Technologies.


While there he managed the build out of a large trading and brokerage floor for Sands Brothers, a NYSE brokerage firm, capable of staffing 400+ brokers, operations and management staff. Becoming a Senior Vice President at Sands, he and the team he managed raised over $100 million for three different private equity funds. Subsequently, Mr. Fear moved onto the New York based Brantley Partners, a very successful private equity fund where he became a principal partner. Ultimately, Mr. Fear left Brantley to take on the position of Associate Director of Business Development for Pergament Advisors, a $700 million dollar Fund of Hedge Funds, where he was primarily responsible for investor relations and development efforts. Most recently Mr. Fear has specialized in the hospitality, food and beverage consulting business, where he has managed a number of projects from concept to implementation as operating partner and general manager at a number of successful restaurants in Honolulu, Hi.

Complete Pharmacy Operations

Managing our pharmacy operations will be one of the world’s largest pharmaceutical services companies serving global markets with a focus on the pharmaceutical supply chain. Servicing both pharmaceutical manufacturers and healthcare providers, this company provides drug distribution and related services designed to reduce costs and improve patient outcomes. They strive to take costs out of the healthcare system by using their scale and efficient operations to drive value for their customers. In addition, to delivering pharmaceuticals on a just-in-time basis to tens of thousands of healthcare providers everyday, they provide business support and consulting services to help their customers focus on their key strength – caring for patients.

Jim Lindsey: Chief Marketing Officer

Mr. Lindsey has 40 years of managerial, creative, and account supervision experience with bottom line responsibilities for international, national, and regional advertising agencies including Saatchi & Saatchi Worldwide, where he served as a Vice-Chairman, Fairfax/Saatchi & Saatchi, McCaffrey & McCall, Hill Holiday/Wakeman & DeForrest, Lindsey, Bradley & Malloy and LBK Holdings.

Mr. Lindsey significantly influenced and directed corporate development, specializing in West Coast and Pacific Rim clients. He also served as Executive Vice President of Hill, Holiday/Wakeman & DeForrest’s West Coast operations. And he has been responsible for national and international agency operations involving business development, marketing, advertising, and strategic planning for worldwide clients including MGM/UA, Orion Films, Sears, Marriott Resorts, Mercedes Benz, DeBeers, Int., T. Row Price, Geneva Corporation, Infinity, MONEX plus Epson Computer Printer Products. Other notable clients included Jenny Craig, Shaw Industries, White Westinghouse, PacTel Cellular/Pacific Telesis, Vartech, RCA, Sears, Mayflower, McDonalds, Carl's Jr., Falcon Jets and The Cotton Council. While Executive


Producer of Metromedia Producers Group, Mr. Lindsey also created and produced primetime specials and network series television releases. Mr. Lindsey has been honored with more than 50 ADDY Awards, Clio Awards, and Golden Quill Awards.

Ned Barnett: Chief Communications Officer

Ned Barnett has more than 40 years of award-winning corporate and non-profit public relations, strategic planning, market research, issues management, fundraising and advertising copywriting experience, much of it in the healthcare field. He has focused on providing these services through national and regional agencies and as an independent consultant.

Mr. Barnett served as Regional Marketing Director and National PR Director for both Republic Health Corporation and AMI Healthcare, and as a partner at both Notch/Bradley and BRAND Marketing. He was also a senior executive at the Silicon Valley subsidiary of Fleishman-Hillard, the world’s largest PR firm. He is a member of the editorial board for PR News – the leading industry trade magazine – and he served as a columnist on Crisis Public Relations for the International Association of Business Communicators’ flagship magazine, CW.

Mr. Barnett earned his BA in Public Relations and did his masters work in Advertising. In 1978, he became the youngest person ever to earn Accreditation by PRSA, and in 1984 he became the first person to be named a Fellow in PR and marketing by the American Hospital Association. He is the only person to have earned four consecutive MacEachern Awards for excellence in healthcare communications.

Russ Kirin: Chief Branding Officer

Mr. Kirin has a broad spectrum of experience in creating high-level business, marketing and communications strategies, as well as producing award-winning tactical solutions for television, radio, film, multimedia, print and the Internet. Mr. Kirin has worked with major agencies and corporations including Burson-Marsteller, Bozell-Kamstra, Ketchum Communications, BrabenderCox, Elias/Savion, printCafe, Westinghouse, ARCO Chemicals and Metropolitan Pittsburgh Public Broadcasting.

At Burson-Marsteller, Mr. Kirin was part of the team that developed and introduced integrated advertising, public relations and special events services to select Burson clients such as Union Carbide, Quaker State and PPG Industries. He received the Clio Award for creating and producing innovative promotions for national sports apparel retailer The Athlete’s Foot.

Most recently, Mr. Kirin has served start-up, small-cap and established companies as a corporate development and marketing consultant, specializing in strategic concepting, development and


planning, branding, marketing communications and interactive development.

BOARD OF ADVISORS

Bruce Silverman is one of America’s best known and most respected marketing-communication and branding experts. He served as EVP/Executive Creative Director at three of America’s largest advertising agencies (Ogilvy, Bozell and BBDO), as President of two of the nation’s best independently-owned agencies (Asher/Gould and WDC), and as President/CEO of the principal U.S. unit of the world’s largest media planning and buying agency (Initiative Worldwide). At Initiative, he also supervised more than $10 billion in annual media planning and buying for more than 500 clients, including Disney, The Home Depot, Electronic Arts, Carl’s Jr., Taco Bell, Acura, Bally’s Health & Fitness, the United States Navy and Yahoo!

Thomas L. Tzikas, M.D. Dr. Thomas L. Tzikas is a graduate of Georgetown University School of Medicine and completed his training in Otolaryngology-Head & Neck Surgery and Facial Plastic & Reconstructive Surgery at Yale University and Walter Reed Army Medical Center in Washington, D.C. Dr. Tzikas is double board certified by the American Board of Facial Plastic & Reconstructive Surgery and the American Board of Otolaryngology.

Dr. Tzikas has been a frequently sought after lecturer at many national and international facial plastic and cosmetic surgical meetings. He has published several academic articles in prestigious surgical journals as well as chapters in books. He has been featured in local newspapers and magazines in South Florida as well as national print and television media. His instructional DVD on full facial rejuvenation with fat grafting has been one of the most popular videos for the American Academy of Facial Plastic & Reconstructive Surgery during the past decade.

___mtm im - bio- 3-9-15

Documents

summary of information

investment summary

information purposes

additional information

result of new information

forwardlooking statements

various remarks

deerfield beach